Govt cancels licences of 18 pharma companies for producing spurious drugs
26 firms have been issued show-cause notices
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Ingredion announces strategic investments to expand into high-value pharma ingredients
As a result of these strategic investments, the company’s portfolio of functional excipients now includes binders, fillers,…
Indian Immunologicals gets regulatory approval for measles-rubella (MR) vaccine
This is the outcome of Indo-Vietnam partnership, where in Indian Immunologicals partnered with Center for Research and Production…
Vantage Nutrition acquires ComboCap
Vantage Nutrition is the only company in the world supplying Sidebyside health products to nutritional and pharmaceutical markets,…
Sanofi gets marketing approval for its diabetes drug Soliqua in India
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
Dr Srinivas Mutalik from Manipal College of Pharmaceutical Sciences gets Sir C.V. Raman Young…
Dr Mutalik is a researcher in the area of advanced drug delivery systems and nanomedicine holding 200 plus publications in reputed…
Boehringer Ingelheim India signs MoU with SIIC, IIT Kanpur for socially impactful innovations
The purpose of this collaboration is to extend support to significant innovations developed at SIIC, IIT Kanpur, with a specific…
Lupin gets tentative US FDA approval for Valbenazine capsules
Valbenazine is indicated for the treatment of tardive dyskinesia (uncontrollable movement of face, tongue, or other body parts)
IIT Kanpur, University at Buffalo sign agreement for R&D in Biomedicine & Bioengineering
The agreement would provide the scope for joint research, exchange of students and researchers, and exchange of academic…
Panbela announces issuance of key patent in Japan
The patent, developed in collaboration with Syngene International, is for claims of a novel process for the production of SBP-101